Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.

Authors: Mrinal M. Gounder, Shreyaskumar Patel, Jason K. Sicklick, Mark Agulnik, Suzanne George, Margaret von Mehren, Xiaoxian Dai, Amitava Mitra, Xiaoyan Yang, Ramya Antony, Blake Tomkinson, Daniel Corum, Mollie Leoni, Tom Kozlek

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11578

Source: Full article

---

Abstract

TPS11578